Rapport Therapeutics, Inc. (RAPP)
40.73
-1.22
(-2.91%)
USD |
NASDAQ |
Sep 18, 15:06
Rapport Therapeutics Price : 40.73 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 42.13 | 42.90 | 41.39 | 41.95 | 397300.0 |
| Sep 16, 2026 | 42.82 | 43.67 | 41.23 | 41.39 | 387026.0 |
| Sep 15, 2026 | 43.87 | 43.98 | 41.76 | 42.68 | 189313.0 |
| Sep 14, 2026 | 44.30 | 44.90 | 43.36 | 44.00 | 196928.0 |
| Sep 11, 2026 | 44.21 | 44.30 | 43.01 | 43.62 | 251788.0 |
| Sep 10, 2026 | 43.35 | 44.00 | 42.65 | 43.46 | 319265.0 |
| Sep 09, 2026 | 45.17 | 45.42 | 43.13 | 43.88 | 437740.0 |
| Sep 08, 2026 | 45.01 | 47.00 | 44.67 | 46.09 | 489386.0 |
| Sep 04, 2026 | 47.63 | 48.00 | 45.52 | 45.77 | 279885.0 |
| Sep 03, 2026 | 48.85 | 49.14 | 47.08 | 47.65 | 276963.0 |
| Sep 02, 2026 | 48.50 | 50.34 | 47.73 | 48.69 | 294754.0 |
| Sep 01, 2026 | 48.17 | 49.38 | 47.90 | 48.56 | 148596.0 |
| Aug 31, 2026 | 48.72 | 49.32 | 47.51 | 48.67 | 221024.0 |
| Aug 28, 2026 | 50.15 | 50.68 | 48.37 | 48.77 | 332731.0 |
| Aug 27, 2026 | 51.88 | 52.93 | 50.60 | 50.83 | 382834.0 |
| Aug 26, 2026 | 50.95 | 52.83 | 50.01 | 52.50 | 275272.0 |
| Aug 25, 2026 | 49.88 | 51.38 | 49.00 | 51.17 | 324500.0 |
| Aug 24, 2026 | 48.16 | 50.34 | 47.44 | 49.33 | 365423.0 |
| Aug 21, 2026 | 48.36 | 48.50 | 47.48 | 48.24 | 140870.0 |
| Aug 20, 2026 | 48.58 | 48.78 | 47.00 | 47.85 | 323724.0 |
| Aug 19, 2026 | 49.58 | 49.90 | 48.62 | 49.07 | 232315.0 |
| Aug 18, 2026 | 47.81 | 49.37 | 47.73 | 49.01 | 214733.0 |
| Aug 17, 2026 | 47.42 | 49.03 | 47.26 | 48.42 | 203969.0 |
| Aug 14, 2026 | 47.00 | 47.64 | 46.37 | 47.42 | 159832.0 |
| Aug 13, 2026 | 48.41 | 48.48 | 46.96 | 47.36 | 242095.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 76.32 |
| Corcept Therapeutics, Inc. | 110.42 |
| Veru, Inc. | 2.41 |
| Johnson & Johnson | 271.66 |
| Eli Lilly & Co. | 1155.44 |
Price Related Metrics
| PS Ratio | 91.45 |
| PEG Ratio | -0.5692 |
| Price to Book Value | 4.618 |
| Earnings Yield | -7.47% |
| Market Cap | 1.953B |
| PEGY Ratio | -0.5692 |